Aptose Biosciences Inc. (TSE:APS – Get Free Report) (NASDAQ:APTO)’s share price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of C$0.70 and traded as low as C$0.26. Aptose Biosciences shares last traded at C$0.26, with a volume of 12,554 shares changing hands.
Aptose Biosciences Stock Down 7.1 %
The company has a quick ratio of 5.41, a current ratio of 0.80 and a debt-to-equity ratio of 670.80. The company has a market cap of C$4.71 million, a PE ratio of -0.04 and a beta of 1.36. The company’s fifty day moving average is C$0.44 and its 200-day moving average is C$0.70.
About Aptose Biosciences
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
Featured Stories
- Five stocks we like better than Aptose Biosciences
- How to Calculate Return on Investment (ROI)
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- High Flyers: 3 Natural Gas Stocks for March 2022
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Aptose Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptose Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
